2021
Bartonellosis in transplant recipients: A retrospective single center experience
Pischel L, Radcliffe C, Vilchez GA, Charifa A, Zhang XC, Grant M. Bartonellosis in transplant recipients: A retrospective single center experience. World Journal Of Transplantation 2021, 11: 244-253. PMID: 34164299, PMCID: PMC8218350, DOI: 10.5500/wjt.v11.i6.244.Peer-Reviewed Original ResearchStem cell transplant recipientsTransplant recipientsCell transplant recipientsClinical presentationDifferential diagnosisAutologous stem cell transplant recipientsHematopoietic stem cell transplant recipientsPost-transplant lymphoproliferative disorderRetrospective single-center experienceSingle-center retrospective studyRenal transplant recipientsSingle-center experienceCat-scratch diseaseCenter experienceClinical courseImmunocompromised hostLymphoproliferative disordersRetrospective studySingle institutionScratch diseaseSolid organsUnknown originDiagnostic testsRecipientsInfectionDeep learning–assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver
Oestmann PM, Wang CJ, Savic LJ, Hamm CA, Stark S, Schobert I, Gebauer B, Schlachter T, Lin M, Weinreb JC, Batra R, Mulligan D, Zhang X, Duncan JS, Chapiro J. Deep learning–assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver. European Radiology 2021, 31: 4981-4990. PMID: 33409782, PMCID: PMC8222094, DOI: 10.1007/s00330-020-07559-1.Peer-Reviewed Original ResearchConceptsNon-HCC lesionsHepatocellular carcinomaHCC lesionsAtypical imagingGrading systemLI-RADS criteriaAtypical imaging featuresPrimary liver cancerTypical hepatocellular carcinomaAtypical hepatocellular carcinomaContrast-enhanced MRISensitivity/specificityLiver transplantMethodsThis IRBRetrospective studyLiver malignanciesImaging featuresLiver cancerAtypical featuresConclusionThis studyLesionsMRIClinical applicationCarcinomaImage-based diagnosis
2020
Splenic-vasculature involvement is associated with poor prognosis in resected distal pancreatic cancer
Yin F, Saad M, Lin J, Jackson CR, Ren B, Lawson C, Karamchandani DM, Bernabeu BQ, Jiang W, Dhir T, Zheng R, Schultz CW, Zhang D, Thomas CL, Zhang X, Lai J, Schild M, Zhang X, Xie H, Liu X. Splenic-vasculature involvement is associated with poor prognosis in resected distal pancreatic cancer. Gastroenterology Report 2020, 9: 139-145. PMID: 34026221, PMCID: PMC8128010, DOI: 10.1093/gastro/goaa084.Peer-Reviewed Original ResearchProgression-free survivalLarger tumor sizeOverall survivalStage pT3Radiographic evidencePrognostic valueTumor sizePancreatic cancerPancreatic carcinomaPredictors of PFSPost-operative adjuvant chemotherapyShorter progression-free survivalDistal pancreatic cancerSplenic artery invasionSplenic vein invasionIndependent risk factorPapillary mucinous neoplasmAdjuvant chemotherapyLymphovascular invasionNodal metastasisVein involvementDistant metastasisPerineural invasionPoor prognosisRetrospective study